
On 5 November, Octin Health, Inc. won the Medical Alley Innovation Showcase in Minneapolis, presented by IDE Group.
The win secures them a place as the US Finalist in the Building Better Futures for Health (BBFH) Challenge 2027. They’ll pitch alongside Asia-Pacific Finalists at the Medical Technology Association of Australia (MTAA) MedTech Conference on 3 March 2027.
Five teams, one place
For more than 10 years, BBFH has backed MedTech founders, this year, the US response was strong enough to need its own semi-finals.
We partnered with Medical Alley, Minnesota’s health technology association, to run a dedicated US track through our Minneapolis office. Ten teams reached the semi-finals. Five advanced to the showcase, where they pitched to investors, founders and industry leaders from the Twin Cities MedTech community.
Five teams took the stage at the showcase. Each working on a real problem for patients and clinicians:
Why Octin Health, Inc. stood out
Octin Health, Inc. is developing Elika, a device designed to make aortic arch operations simpler and more efficient, and to cut operating times.
Dr. Helder is a practicing cardiac surgeon. Aortic arch operations are the highest-risk interventions in cardiac surgery, and national data still shows high rates of death and complications. For patients, that means a dangerous operation with little margin for error. For surgeons, it means technically demanding work without a tool built for the job. Dr. Helder and her team designed Elika to change that.
When we opened BBFH to US founders and start ups, we hoped to find teams like Octin Health, where Dr. Helder and their team showed a clear understanding of both the clinical problem and an aggressive path to bring it market. We’re looking forward to seeing them on the stage in Sydney.
The road to Sydney
Octin Health, Inc. now joins our Asia-Pacific Finalists for the BBFH Grand Finals on 3 March 2027. Finalists compete for AU$30,000 in IDE Group services across strategy, product development, human factors engineering and manufacturing. A People’s Choice Award of AU$10,000 in services is also on offer.
Beyond the financial incentives, the Challenge is distinguished by its emphasis on collaboration, mentorship, and long-term capability building. Finalists benefit from individualized guidance provided by IDE Group’s multidisciplinary teams of engineers, designers, and clinicians, bringing together deep sectoral knowledge, technical excellence, and a shared commitment to advancing Australia’s MedTech innovation frontier.
It will be the first time a US team has taken the BBFH stage in Australia. IDE is sponsoring their trip as part of our continued investment in the US and global MedTech sector.
The Twin Cities has some of the strongest early-stage MedTech talent in the world, and our ongoing Innovation Showcase helps prove it. Octin Health, Inc. now has the chance to take that work to an international audience. We’re proud to have supported every team that came through this process.
Contact for Media Inquires:
Matt Allison
Marketing Manager
IDE Group
Phone: +61 2 9647 2660
Address: 701-703 Paramatta Rd,
Leichhardt, NSW 2040. Australia
Email: partnering@ide.group



